NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...

A technology has been developed that can screen for lung cancer at an early stage using exhaled breath. This technology demonstrated 95% accuracy in clinical settings. It is expected to contribute to ...

Qure.ai aims to capture more market share globally, including the US, by next year. Lung cancer is the leading cause of cancer death worldwide, accounting for about 2.4 million patients diagnosed and ...

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...

Please provide your email address to receive an email when new articles are posted on . Patients with limited-stage small cell lung cancer with ctDNA positivity after chemotherapy had significant ...